Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
XBH107
- Development stage
- Preclinical
- Lead developer
- Shanghai XBH Biotechnology
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
01
Overview
XBH107 is an investigational antibody-drug conjugate (ADC) currently in preclinical development by GV20 Oncotherapy. The drug is designed to treat ovarian and endometrial cancers by utilizing a monoclonal antibody to deliver a cytotoxic payload specifically to tumor cells. Developed using GV20's proprietary AI-driven platform, which identifies novel targets from large-scale genomic and clinical data, XBH107 represents a targeted approach to gynecological malignancies. As of the current pipeline status, the specific molecular target and the nature of the cytotoxic payload have not been publicly disclosed.
- Other names
- XBH107-GV20 Oncotherapy-ADC-Ovarian and EndometrialXBH-107-GV20 Oncotherapy-ADC-Ovarian and EndometrialXBH 107-GV20 Oncotherapy-ADC-Ovarian and Endometrial
Beyond the preview
Go deeper on XBH107.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XBH107.